- Article metrics
- Last updated: Wed, 8 Oct 2025 21:26:18 Z
Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial
Access & Citations
-
- 6069
- Article Accesses
-
- 0
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
Online attention
- 4 tweeters
- 1 news outlets
- 4 Mendeley
This article is in the 86th percentile (ranked 38,594th) of the 286,353 tracked articles of a similar age in all journals and the 37th percentile (ranked 28th) of the 45 tracked articles of a similar age in Nature Cancer
View more on Altmetric
Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.
Mentions in news and blogs
This list highlights individual mainstream news articles and blogs that cite the article. Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media. Altmetric are responsible for the curation of this list and provide updates hourly.
